Functional Screening of FxxLF-Like Peptide Motifs Identifies SMARCD1/BAF60a as an Androgen Receptor Cofactor that Modulates TMPRSS2 Expression

le van de Wijngaart, Dennis J., Dubbink, Hendrikus J., Molier, Michel, de Vos, Carola, Trapman, Jan, Jenster, Guido
Foilsithe in Mol Endocrinol (2009)

Systematic Structure-Function Analysis of Androgen Receptor Leu(701) Mutants Explains the Properties of the Prostate Cancer Mutant L701H

le van de Wijngaart, Dennis J., Molier, Michel, Lusher, Scott J., Hersmus, Remko, Jenster, Guido, Trapman, Jan, Dubbink, Hendrikus J.
Foilsithe 2010

Novel EGFR V834L Germline Mutation Associated With Familial Lung Adenocarcinoma

le van der Leest, Cor, Wagner, Anja, Pedrosa, Rute M., Aerts, Joachim G., Dinjens, Winand N.M., Dubbink, Hendrikus J.
Foilsithe in JCO Precis Oncol (2018)

Mitochondrial D310 mutation as clonal marker for solid tumors

le Geurts-Giele, Willemina R. R., Gathier, Gerard H. G. K., Atmodimedjo, Peggy N., Dubbink, Hendrikus J., Dinjens, Winand N. M.
Foilsithe in Virchows Arch (2015)

MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation

le Groenendijk, Floris H., Taal, Walter, Dubbink, Hendrikus J., Haarloo, Cathleen R., Kouwenhoven, Mathilde C., van den Bent, Martin J., Kros, Johan M., Dinjens, Winand N. M.
Foilsithe 2010

Impact of panel design and cut-off on tumour mutational burden assessment in metastatic solid tumour samples

le Mankor, Joanne M., Paats, Marthe S., Groenendijk, Floris H., Roepman, Paul, Dinjens, Winand N. M., Dubbink, Hendrikus J., Sleijfer, Stefan, Cuppen, Edwin, Lolkema, Martijn P. J. K.
Foilsithe in Br J Cancer (2020)

Compartmentalization of androgen receptor protein–protein interactions in living cells

le van Royen, Martin E., Cunha, Sónia M., Brink, Maartje C., Mattern, Karin A., Nigg, Alex L., Dubbink, Hendrikus J., Verschure, Pernette J., Trapman, Jan, Houtsmuller, Adriaan B.
Foilsithe 2007

Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics

le Synhaeve, Nathalie E., van den Bent, Martin J., French, Pim J., Dinjens, Winand N. M., Atmodimedjo, Peggy N., Kros, Johan M., Verdijk, R., Dirven, Clemens M. F., Dubbink, Hendrikus J.
Foilsithe in Acta Neuropathol Commun (2018)

Gynecological Surveillance and Surgery Outcomes in Dutch Lynch Syndrome Carriers

le Eikenboom, Ellis L., van Doorn, Helena C., Dinjens, Winand N. M., Dubbink, Hendrikus J., Geurts-Giele, Willemina R. R., Spaander, Manon C. W., Tops, Carli M. J., Wagner, Anja, Goverde, Anne
Foilsithe in Cancers (Basel) (2021)

Next generation diagnostic molecular pathology: Critical appraisal of quality assurance in Europe

le Dubbink, Hendrikus J., Deans, Zandra C., Tops, Bastiaan B.J., van Kemenade, Folkert J., Koljenović, S., van Krieken, Han J.M., Blokx, Willeke A.M., Dinjens, Winand N.M., Groenen, Patricia J.T.A.
Foilsithe in Mol Oncol (2014)

The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study

le Broen, Martinus P G, Smits, Marion, Wijnenga, Maarten M J, Dubbink, Hendrikus J, Anten, Monique H M E, Schijns, Olaf E M G, Beckervordersandforth, Jan, Postma, Alida A, van den Bent, Martin J
Foilsithe in Neuro Oncol (2018)

Topographical Mapping of 436 Newly Diagnosed IDH Wildtype Glioblastoma With vs. Without MGMT Promoter Methylation

le Incekara, Fatih, van der Voort, Sebastian R., Dubbink, Hendrikus J., Atmodimedjo, Peggy N., Nandoe Tewarie, Rishi, Lycklama, Geert, Vincent, Arnaud J. P. E., Kros, Johan M., Klein, Stefan, van den Bent, Martin, Smits, Marion
Foilsithe in Front Oncol (2020)

Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial

le Dubbink, Hendrikus J., Atmodimedjo, Peggy N., Kros, Johan M., French, Pim J., Sanson, Marc, Idbaih, Ahmed, Wesseling, Pieter, Enting, Roelien, Spliet, Wim, Tijssen, Cees, Dinjens, Winand N. M., Gorlia, Thierry, van den Bent, Martin J.
Foilsithe in Neuro Oncol (2016)

Prognostic relevance of mutations and copy number alterations assessed with targeted next generation sequencing in IDH mutant grade II glioma

le Wijnenga, Maarten M. J., French, Pim J., Dubbink, Hendrikus J., Dinjens, Winand N. M., Atmodimedjo, Peggy N., Kros, Johan M., Fleischeuer, Ruth, Dirven, Clemens M. F., Vincent, Arnaud J. P. E., van den Bent, Martin J.
Foilsithe in J Neurooncol (2018)

Molecular Genetics of Conjunctival Melanoma and Prognostic Value of TERT Promoter Mutation Analysis

le van Poppelen, Natasha M., van Ipenburg, Jolique A., van den Bosch, Quincy, Vaarwater, Jolanda, Brands, Tom, Eussen, Bert, Magielsen, Frank, Dubbink, Hendrikus J., Paridaens, Dion, Brosens, Erwin, Naus, Nicole, de Klein, Annelies, Kiliç, Emine, Verdijk, Robert M.
Foilsithe in Int J Mol Sci (2021)

The Erasmus Glioma Database (EGD): Structural MRI scans, WHO 2016 subtypes, and segmentations of 774 patients with glioma

le van der Voort, Sebastian R., Incekara, Fatih, Wijnenga, Maarten M.J., Kapsas, Georgios, Gahrmann, Renske, Schouten, Joost W., Dubbink, Hendrikus J., Vincent, Arnaud J.P.E., van den Bent, Martin J., French, Pim J., Klein, Stefan, Smits, Marion
Foilsithe in Data Brief (2021)

Comparison of variant allele frequency and number of mutant molecules as units of measurement for circulating tumor DNA

le Bos, Manouk K., Nasserinejad, Kazem, Jansen, Maurice P. H. M., Angus, Lindsay, Atmodimedjo, Peggy N., de Jonge, Evert, Dinjens, Winand N. M., van Schaik, Ron H. N., Del Re, Marzia, Dubbink, Hendrikus J., Sleijfer, Stefan, Martens, John W. M.
Foilsithe in Mol Oncol (2020)

MGMT Promoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Stu...

le van den Bent, Martin J., Dubbink, Hendrikus J., Sanson, Marc, van der Lee-Haarloo, Cathleen R., Hegi, Monika, Jeuken, Judith W.M., Ibdaih, Ahmed, Brandes, Alba A., Taphoorn, Martin J.B., Frenay, Marc, Lacombe, Denis, Gorlia, Thierry, Dinjens, Winand N.M., Kros, Johan M.
Foilsithe 2009

Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria

le Tesileanu, C Mircea S, Dirven, Linda, Wijnenga, Maarten M J, Koekkoek, Johan A F, Vincent, Arnaud J P E, Dubbink, Hendrikus J, Atmodimedjo, Peggy N, Kros, Johan M, van Duinen, Sjoerd G, Smits, Marion, Taphoorn, Martin J B, French, Pim J, van den Bent, Martin J
Foilsithe in Neuro Oncol (2020)

The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis

le Wijnenga, Maarten M J, French, Pim J, Dubbink, Hendrikus J, Dinjens, Winand N M, Atmodimedjo, Peggy N, Kros, Johan M, Smits, Marion, Gahrmann, Renske, Rutten, Geert-Jan, Verheul, Jeroen B, Fleischeuer, Ruth, Dirven, Clemens M F, Vincent, Arnaud J P E, van den Bent, Martin J
Foilsithe in Neuro Oncol (2018)